Baird Maintains Neutral on Genpact, Raises Price Target to $44
Portfolio Pulse from Benzinga Newsdesk
Baird analyst David Koning maintains a Neutral rating on Genpact (NYSE:G) but raises the price target from $38 to $44.
October 09, 2024 | 11:22 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Baird analyst David Koning has maintained a Neutral rating on Genpact but increased the price target from $38 to $44, indicating a positive outlook on the stock's potential.
The increase in price target from $38 to $44 suggests a positive outlook on Genpact's future performance, which could lead to a short-term increase in stock price. However, the Neutral rating indicates that the analyst does not see a strong buy opportunity, balancing the impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100